Search results
Axsome (AXSM) Starts Late-Stage Study of Migraine Drug AXS-07
Zacks via Yahoo Finance· 2 years agoAxsome AXSM announced the enrollment of the first patient in the EMERGE phase III open label study...
The Top Health Deals on Amazon This Week—Including 80% Off a Popular Massage Gun
Health via Yahoo News· 1 year agoDotdash Meredith and Yahoo Inc. may earn commission or revenue on some items through the links...
Axsome Triumphs Over Major Depressive Disorder With Auvelity
GuruFocus.com via Yahoo Finance· 3 months agoAxsome Therapeutics Inc. (NASDAQ:AXSM) is a fast-growing pharmaceutical company headquartered in New...
Axsome (AXSM) Q4 Earnings Miss, Auvelity Records First Sales
Zacks via Yahoo Finance· 1 year agoAxsome Therapeutics, Inc. AXSM incurred an adjusted loss of $1.28 per share in the fourth quarter of...
Axsome (AXSM) Q3 Loss Narrower Than Expected, Revenues Miss
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics, Inc. AXSM incurred a loss of $1.03 per share (excluding intangible asset...
Mizuho Bolsters Price Target By 55% On This Migraine Stock
Benzinga via Yahoo Finance· 2 years agoMizuho Securities assumes coverage of Axsome Therapeutics Inc (NASDAQ: AXSM), with a Buy rating and...
Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat
Zacks via Yahoo Finance· 4 months agoAxsome Therapeutics, Inc. AXSM reported an adjusted loss of 73 cents per share for the fourth...
AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises '23 View
Zacks via Yahoo Finance· 11 months agoAbbVie Inc. ABBV reported adjusted earnings of $2.91 per share for second-quarter 2023, beating the...
Pharma Stock Roundup: JNJ, NVS Q2 Earnings, GSK Consumer Unit Spin-Off
Zacks via Yahoo Finance· 2 years agoThis week, J&J JNJ set in motion the second-quarter earnings season for the drug and biotech sector...
Axsome (AXSM) Initiates Late-Stage Alzheimer's Agitation Study
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics AXSM announced that the first patient has been enrolled in the ADVANCE-2 phase...